VRTX Balance Sheet
Vertex Pharmaceuticals Inc - Assets, Liabilities & Stockholders' Equity
Total Assets
$22.53B
Total Liabilities
$6.12B
Shareholders' Equity
$16.41B
Cash Position
$4.57B
Assets
As of: FY
Current Assets
Cash & Equivalents
$4.57B
Total Current Assets
$9.60B
Non-Current Assets
Total Assets
$22.53B
Liabilities & Equity
Current Liabilities
Total Current Liabilities
$3.56B
Non-Current Liabilities
Total Liabilities
$6.12B
Stockholders' Equity
Retained Earnings
$9.61B
Total Equity
$16.41B
Total Liabilities & Equity
$22.53B
Should equal Total Assets
Key Balance Sheet Ratios
Current Ratio
2.69
Current Assets / Current Liabilities
Working Capital
$6.03B
Current Assets - Current Liabilities
Balance Sheet Health
Liquidity: Strong
Current ratio of 2.69 indicates the company has ample short-term assets to cover short-term liabilities.
Cash Position: 20.3% of Assets
$4.57B in cash provides strong financial flexibility.
View Complete Financial Analysis
Explore detailed financials, income statements, cash flows, and more
Open Full FinancialsFrequently Asked Questions
What are VRTX's total assets?
VRTX has total assets of $22.53B, down from $22.53B in the previous period.
How much debt does VRTX have?
Debt information for VRTX can be found in the balance sheet.
What is VRTX's cash position?
VRTX has $4.57B in cash and cash equivalents, representing 20.3% of total assets.
What is VRTX's stockholders' equity?
VRTX's stockholders' equity is $16.41B. This represents the book value of the company and shareholder ownership stake.
What is VRTX's current ratio?
VRTX has a current ratio of 2.69. This means the company has $2.69 in current assets for every $1 in current liabilities. A ratio above 1.0 indicates good short-term financial health.
How healthy is VRTX's balance sheet?
VRTX's balance sheet shows $22.53B in total assets, $6.12B in liabilities, and $16.41B in equity. The current ratio of 2.69 suggests strong liquidity.